Rianlon Past Earnings Performance
Past criteria checks 2/6
Rianlon has been growing earnings at an average annual rate of 13.9%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 25.3% per year. Rianlon's return on equity is 8.5%, and it has net margins of 7.1%.
Key information
13.9%
Earnings growth rate
9.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 25.3% |
| Return on equity | 8.5% |
| Net Margin | 7.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Investors Still Aren't Entirely Convinced By Rianlon Corporation's (SZSE:300596) Earnings Despite 33% Price Jump
Apr 29
Rianlon Corporation Just Missed EPS By 7.9%: Here's What Analysts Think Will Happen Next
Apr 21Does Rianlon (SZSE:300596) Have A Healthy Balance Sheet?
Mar 25There's No Escaping Rianlon Corporation's (SZSE:300596) Muted Earnings Despite A 26% Share Price Rise
Mar 06Revenue & Expenses BreakdownBeta
How Rianlon makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 5,447 | 387 | 356 | 261 |
| 31 Dec 23 | 5,278 | 362 | 337 | 233 |
| 30 Sep 23 | 5,106 | 374 | 333 | 189 |
| 30 Jun 23 | 5,081 | 434 | 321 | 216 |
| 31 Mar 23 | 5,018 | 482 | 308 | 202 |
| 01 Jan 23 | 4,843 | 526 | 299 | 208 |
| 30 Sep 22 | 4,514 | 553 | 271 | 199 |
| 30 Jun 22 | 4,096 | 506 | 256 | 179 |
| 31 Mar 22 | 3,634 | 453 | 246 | 157 |
| 31 Dec 21 | 3,445 | 418 | 236 | 151 |
| 30 Sep 21 | 3,270 | 379 | 251 | 123 |
| 30 Jun 21 | 2,960 | 344 | 236 | 112 |
| 31 Mar 21 | 2,741 | 320 | 217 | 111 |
| 31 Dec 20 | 2,483 | 293 | 198 | 102 |
| 30 Sep 20 | 2,282 | 257 | 201 | 110 |
| 30 Jun 20 | 2,253 | 272 | 195 | 103 |
| 31 Mar 20 | 2,132 | 272 | 193 | 89 |
| 31 Dec 19 | 1,978 | 262 | 198 | 80 |
| 30 Sep 19 | 1,792 | 264 | 152 | 82 |
| 30 Jun 19 | 1,640 | 232 | 165 | 64 |
| 31 Mar 19 | 1,574 | 211 | 164 | 69 |
| 31 Dec 18 | 1,488 | 193 | 152 | 67 |
| 30 Sep 18 | 1,401 | 185 | 164 | 59 |
| 30 Jun 18 | 1,295 | 159 | 114 | 86 |
| 31 Mar 18 | 1,181 | 136 | 118 | 66 |
| 31 Dec 17 | 1,142 | 131 | 121 | 53 |
| 30 Sep 17 | 1,089 | 111 | 126 | 37 |
| 30 Jun 17 | 989 | 99 | 148 | 0 |
| 31 Mar 17 | 899 | 96 | 129 | 0 |
| 31 Dec 16 | 808 | 91 | 112 | 0 |
| 30 Sep 16 | 719 | 90 | 83 | 0 |
| 31 Dec 15 | 605 | 74 | 74 | 0 |
| 31 Dec 14 | 488 | 45 | 61 | 0 |
| 31 Dec 13 | 404 | 40 | 50 | 0 |
Quality Earnings: 300596 has high quality earnings.
Growing Profit Margin: 300596's current net profit margins (7.1%) are lower than last year (9.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300596's earnings have grown by 13.9% per year over the past 5 years.
Accelerating Growth: 300596's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300596 had negative earnings growth (-19.8%) over the past year, making it difficult to compare to the Chemicals industry average (-19.7%).
Return on Equity
High ROE: 300596's Return on Equity (8.5%) is considered low.